FK

Firoj Khan

Active Director Director DIN 08452452
DIN 08452452 First appointment May 2019 Primary industry Home Appliances
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2019
Shareholding value •••• Premium profile

About Firoj Khan

Data last updated:

Firoj Khan is a Director at Synon Pharmaceuticals Private Limited (since 2019). The company operates in Home Appliances. Synon Pharmaceuticals Private Limited reported revenue of ₹48.4 Lakh (FY 2025).

DIN 08452452
Primary Designation Director
Industry Home Appliances
First Appointment 14 May 2019
Oldest Company Age 7 yrs
Largest company Synon Pharmaceuticals Private Limited · ₹48.4 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 May 20192019₹48.4 Lakh (FY 2025)Active

Board colleagues of Firoj Khan

Directorship timeline

Open interactive timeline →
Synon Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Firoj Khan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Firoj Khan

Firoj Khan currently holds 1 directorship: Synon Pharmaceuticals Private Limited (Director, since 14 May 2019, revenue ₹48.4 Lakh (FY 2025)).

Firoj Khan was first appointed on 14 May 2019 as Director at Synon Pharmaceuticals Private Limited.

The current boards of Firoj Khan's companies include Avinash Kumar (Synon Pharmaceuticals Private Limited), Sikandar (Synon Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available